ssDNA Viruses

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA

C12N2750/00ssDNA Viruses

C12N2750/00011ssDNA Viruses C12N2750/00021Viruses as such C12N2750/00022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2750/00023Virus like particles [VLP] C12N2750/00031Uses of virus other than therapeutic or vaccine C12N2750/00032Use of virus as therapeutic agent, other than vaccine C12N2750/00033Use of viral protein as therapeutic agent other than vaccine C12N2750/00034Use of virus or viral component as vaccine C12N2750/00041Use of virus, viral particle or viral elements as a vector C12N2750/00042virus or viral particle as vehicle C12N2750/00043viral genome or elements thereof as genetic vector C12N2750/00044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2750/00045Special targeting system for viral vectors C12N2750/00051Methods of production or purification of viral material C12N2750/00052relating to complementing cells and packaging systems for producing virus or viral particles C12N2750/00061Methods of inactivation or attenuation C12N2750/00062by genetic engineering C12N2750/00063by chemical treatment C12N2750/00064by serial passage C12N2750/00071Demonstrated in vivo effect C12N2750/00088For redistribution C12N2750/10011Circoviridae C12N2750/10021Viruses as such C12N2750/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2750/10023Virus like particles [VLP] C12N2750/10031Uses of virus other than therapeutic or vaccine C12N2750/10032Use of virus as therapeutic agent, other than vaccine C12N2750/10033Use of viral protein as therapeutic agent other than vaccine C12N2750/10034Use of virus or viral component as vaccine C12N2750/10041Use of virus, viral particle or viral elements as a vector C12N2750/10042virus or viral particle as vehicle C12N2750/10043viral genome or elements thereof as genetic vector C12N2750/10044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2750/10045Special targeting system for viral vectors C12N2750/10051Methods of production or purification of viral material C12N2750/10052relating to complementing cells and packaging systems for producing virus or viral particles C12N2750/10061Methods of inactivation or attenuation C12N2750/10062by genetic engineering C12N2750/10063by chemical treatment C12N2750/10064by serial passage C12N2750/10071Demonstrated in vivo effect C12N2750/10088For redistribution C12N2750/12011Geminiviridae C12N2750/12021Viruses as such C12N2750/12022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2750/12023Virus like particles [VLP] C12N2750/12031Uses of virus other than therapeutic or vaccine C12N2750/12032Use of virus as therapeutic agent, other than vaccine C12N2750/12033Use of viral protein as therapeutic agent other than vaccine C12N2750/12034Use of virus or viral component as vaccine C12N2750/12041Use of virus, viral particle or viral elements as a vector C12N2750/12042virus or viral particle as vehicle C12N2750/12043viral genome or elements thereof as genetic vector C12N2750/12044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2750/12045Special targeting system for viral vectors C12N2750/12051Methods of production or purification of viral material C12N2750/12052relating to complementing cells and packaging systems for producing virus or viral particles C12N2750/12061Methods of inactivation or attenuation C12N2750/12062by genetic engineering C12N2750/12063by chemical treatment C12N2750/12064by serial passage C12N2750/12071Demonstrated in vivo effect C12N2750/12088For redistribution C12N2750/14011Parvoviridae C12N2750/14021Viruses as such C12N2750/14022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2750/14023Virus like particles [VLP] C12N2750/14031Uses of virus other than therapeutic or vaccine C12N2750/14032Use of virus as therapeutic agent, other than vaccine C12N2750/14033Use of viral protein as therapeutic agent other than vaccine C12N2750/14034Use of virus or viral component as vaccine C12N2750/14041Use of virus, viral particle or viral elements as a vector C12N2750/14042virus or viral particle as vehicle C12N2750/14043viral genome or elements thereof as genetic vector C12N2750/14044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2750/14045Special targeting system for viral vectors C12N2750/14051Methods of production or purification of viral material C12N2750/14052relating to complementing cells and packaging systems for producing virus or viral particles C12N2750/14061Methods of inactivation or attenuation C12N2750/14062by genetic engineering C12N2750/14063by chemical treatment C12N2750/14064by serial passage C12N2750/14071Demonstrated in vivo effect C12N2750/14088For redistribution C12N2750/14111Dependovirus C12N2750/14121Viruses as such C12N2750/14122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2750/14123Virus like particles [VLP] C12N2750/14131Uses of virus other than therapeutic or vaccine C12N2750/14132Use of virus as therapeutic agent, other than vaccine C12N2750/14133Use of viral protein as therapeutic agent other than vaccine C12N2750/14134Use of virus or viral component as vaccine C12N2750/14141Use of virus, viral particle or viral elements as a vector C12N2750/14142virus or viral particle as vehicle C12N2750/14143viral genome or elements thereof as genetic vector C12N2750/14144Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2750/14145Special targeting system for viral vectors C12N2750/14151Methods of production or purification of viral material C12N2750/14152relating to complementing cells and packaging systems for producing virus or viral particles C12N2750/14161Methods of inactivation or attenuation C12N2750/14162by genetic engineering C12N2750/14163by chemical treatment C12N2750/14164by serial passage C12N2750/14171Demonstrated in vivo effect C12N2750/14188For redistribution C12N2750/14211Erythrovirus C12N2750/14221Viruses as such C12N2750/14222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2750/14223Virus like particles [VLP] C12N2750/14231Uses of virus other than therapeutic or vaccine C12N2750/14232Use of virus as therapeutic agent, other than vaccine C12N2750/14233Use of viral protein as therapeutic agent other than vaccine C12N2750/14234Use of virus or viral component as vaccine C12N2750/14241Use of virus, viral particle or viral elements as a vector C12N2750/14242virus or viral particle as vehicle C12N2750/14243viral genome or elements thereof as genetic vector C12N2750/14244Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2750/14245Special targeting system for viral vectors C12N2750/14251Methods of production or purification of viral material C12N2750/14252relating to complementing cells and packaging systems for producing virus or viral particles C12N2750/14261Methods of inactivation or attenuation C12N2750/14262by genetic engineering C12N2750/14263by chemical treatment C12N2750/14264by serial passage C12N2750/14271Demonstrated in vivo effect C12N2750/14288For redistribution C12N2750/14311Parvovirus C12N2750/14321Viruses as such C12N2750/14322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2750/14323Virus like particles [VLP] C12N2750/14331Uses of virus other than therapeutic or vaccine C12N2750/14332Use of virus as therapeutic agent, other than vaccine C12N2750/14333Use of viral protein as therapeutic agent other than vaccine C12N2750/14334Use of virus or viral component as vaccine C12N2750/14341Use of virus, viral particle or viral elements as a vector C12N2750/14342virus or viral particle as vehicle C12N2750/14343viral genome or elements thereof as genetic vector C12N2750/14344Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2750/14345Special targeting system for viral vectors C12N2750/14351Methods of production or purification of viral material C12N2750/14352relating to complementing cells and packaging systems for producing virus or viral particles C12N2750/14361Methods of inactivation or attenuation C12N2750/14362by genetic engineering C12N2750/14363by chemical treatment C12N2750/14364by serial passage C12N2750/14371Demonstrated in vivo effect C12N2750/14388For redistribution